Skip to search formSkip to main contentSkip to account menu

Schindler Disease, Type II

Known as: Alpha-N-acetylgalactosaminidase deficiency type 2, NAGA Deficiency, Type II, ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE II 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
The enantiomers of XYLNAc (2-N-acetylamino-1,2,4-trideoxy-1,4-iminoxylitol) are prepared from the enantiomers of glucuronolactone… 
2013
2013
Rationale: Visceral adipose tissue-derived serine proteinase inhibitor (vaspin) is an adipokine identified from visceral adipose… 
2007
2007
Summaryα-N-Acetylgalactosaminidase deficiency is a lysosomal disorder with clinically very different infantile and adult forms… 
2006
2006
We would like to draw attention to a recent discovery that may explain the striking discordance between the clinical and… 
2002
2002
An α-N-acetylgalactosaminidase IV able to remove blood type specificity of human A(II)-erythrocytes and not effecting B(III… 
2001
2001
Two new individuals with α-NAGA deficiency are presented. The index patient, 3 years old, has congenital cataract, slight motor… 
Review
1990
Review
1990
SummaryThe clinical, pathological and biochemical features of a neuroaxonal dystrophy resulting from the deficient activity of… 
1988
1988
SummaryA new lysosomal storage disease with autosomal recessive inheritance is described in two male siblings of 5 1/2 and 4…